Application no. and date | 17207731.5 (espacenet) (Federated) (European Patent Register), 20111115 | Patent/reg. no. and date | DK/EP 3326615, 20200108 | Publication date | 20180530 | Priority no. and date | US 413637 P, 20101115, US 201161524064 P, 20110816 | EP pub. no. and date |
EP 3326615 20180530 | Effective date | | Applicant/owner | Neuroderm Ltd, 3 Pekeris Street Rabin Science Park 7670212 Rehovot, IL | Applicant ref. no. | P62000096DK00E | Inventor | YACOBY-ZEEVI, Oron, 204 Hanarkissim Street
60946 Bitsaron, IL, NEMAS, Mara, 17/4 Ha'atsmaut Street
70700 Gedera, IL | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/195 (2006.01) , A61K 31/198 (2006.01) , A61K 9/08 (2006.01) , A61P 25/16 (2006.01) | Title | KONTINUERLIG INDGIVELSE AF L-DOPA-, DOPA- DECARBOXYLASE-INHIBITORER, CATECHOL-O-METHYLTRANSFERASEINHIBITORER OG SAMMENSÆTNINGER TIL SAMME | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|